peroxynitrous acid has been researched along with Inflammatory Bowel Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| D'Alessio, A; Fieschi, F; Jaquet, V; Knaus, UG; McLoughlin, RM; Michalski, R; Sikora, A; Ward, J; Yin, Y; Zhang, S | 1 |
| Alhasson, F; Berger, FG; Carson, J; Chandrashekaran, V; Chatterjee, S; Dattaroy, D; Diehl, AM; Kalyanaraman, B; Seth, RK; Ziolenka, J | 1 |
| Kim, HE; Kwak, Y; Park, SG | 1 |
1 review(s) available for peroxynitrous acid and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases.
Topics: Animals; Arginase; Arthritis; Asthma; Autoimmunity; Dendritic Cells; Hepatitis, Autoimmune; Humans; Immune System; Immune Tolerance; Inflammation; Inflammatory Bowel Diseases; Killer Cells, Natural; Lymphocyte Activation; Multiple Sclerosis; Myeloid Cells; Neoplasms; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Phenotype; Prognosis; Reactive Oxygen Species; T-Lymphocytes, Regulatory | 2015 |
2 other study(ies) available for peroxynitrous acid and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
VEO-IBD NOX1 variant highlights a structural region essential for NOX/DUOX catalytic activity.
Topics: Asparagine; Humans; Inflammatory Bowel Diseases; NADPH Oxidase 1; NADPH Oxidases; Peroxynitrous Acid; Reactive Oxygen Species | 2023 |
HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.
Topics: Animals; Cell Line; Cytokines; Enterocytes; HMGB1 Protein; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Non-alcoholic Fatty Liver Disease; Peroxynitrous Acid; Rats; Receptor for Advanced Glycation End Products; Signal Transduction; Toll-Like Receptor 4 | 2017 |